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Abstract
Depression is the most common neuropsychiatric disorder affecting over one 
third of all stroke patients. The presence of depression after a stroke greatly affects 
the ability of patients to participate in rehabilitation and can even affect their 
long-term mortality. Poststroke depression is a well-documented and studied aspect 
of stroke management because of the implications it has on morbidity, mortality 
and recovery. Despite post stroke depression being a well-studied phenomenon, 
it remains underdiagnosed. The development of poststroke depression is 
multifactorial and has been evaluated from the cellular, genetic, and environmental 
perspective. Using numerous studies this chapter will review facets of post stroke 
depression such as epidemiology, etiology and treatment, while evaluating how this 
phenomena effects patient recovery and rehabilitation.
Keywords: stroke, depression, post stroke depression, elderly, serotonin, anxiety, 
recovery, rehabilitation, function, rehab, acute stroke, ischemic, hemorrhagic, mood
1. Introduction
Stroke is one of the leading causes of long-term disability in the United States 
and is the third leading cause of mortality [1]. Brain parenchyma is densely packed 
with millions of neurons, where any assault such as an ischemic or hemorrhagic 
stroke can leave a patient with debilitating deficits [2]. A few of these deficits 
include the inability to speak or understand language; loss of vision, complete 
paralysis of one side of the body, quadriplegia, persistent balance issues, and loss of 
the ability swallow independently. Neuropsychological changes are also very com-
mon and well documented in poststroke patients; however, the number of patients 
that suffer from these changes are grossly underestimated [3].
More than one-third of all stroke survivors experience some form of depression 
[4]. Depression after a stroke can manifest in many different ways including feel-
ings of anger, frustration, hopelessness, guilt, mental slowing, fatigue, irritability, 
changes in appetite, social withdrawal, loss of interest in activities they once found 
enjoyable (also known as anhedonia), or even suicidal thoughts [2]. Patients that 
suffer from poststroke depression, often have these symptoms missed or under-
treated. Recovery and rehabilitation can be adversely affected if post stroke depres-
sion is not adequately treated. This can result in increased length of stay at postacute 
care facilities, increased morbidity, decreased quality of life and even increased 
mortality [5]. Numerous depression scales have been used to define poststroke 
depression including the Beck Depression Inventory (BDI), Montgomery-Åsberg 
Depression Rating Scale (MADRS), Centre for Epidemiologic Studies Depression 
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scale (CES-D), Zung self-rating depression scale and the Hamilton Depression 
Rating Scale (HDRS) [5]. Post stroke depression has a great impact on the health-
care system as well as on the individual patient. In this chapter, we will examine 
all aspect of depression as it relates to stroke by using these scales and large meta-
analyses to define post-stroke depression, and assess how it relates to stroke and 
recovery.
2. Epidemiology
Advancements in acute medical therapies have led to the reduction of mortality 
due to acute ischemic or hemorrhagic stroke [5]. Studies have shown that 10% of 
patients recover without any residual deficits, a quarter have mild residual deficits, 
while 50% are severely disabled or require skilled nursing care within a medi-
cal facility able to manage their needs [6]. Along with severe physical disability, 
patients that suffer from a stroke also experience neuropsychiatric changes. The 
most common neuropsychiatric sequelae, post-stroke, are depression and anxiety 
[7]. Patients that survive stroke often experience anxiety and depression related to 
making adjustments to their new reality [7]. With more patients surviving stroke, 
quality of life becomes an area of focus. Poststroke depression has been regarded 
as one of the most important measures for quality of life after an acute stroke. The 
presence of depression after stroke results in impaired recovery, decreased par-
ticipation in rehab efforts, impaired cognition, and even increased mortality. The 
majority of the expressed concern from patients is related to their ability to work 
and provide financial stability for themselves/their families, the ability to manage 
their activities of daily living, and the loss of their functional independence [7].
The term poststroke depression puts a focus on ischemic rather than hemor-
rhagic strokes, which is mostly due to the fact that ischemic strokes have been stud-
ied more in the literature, and thus will be the focus of this chapter [8]. Poststroke 
depression can occur anywhere from days to years after an acute ischemic event 
with the peak incidence of poststroke depression occurring between 3 months and 
2 years, even if the patient’s symptoms are improving [9]. Patients that experi-
ence the onset of poststroke depression at or after 7 weeks from the acute event 
are less likely to have a spontaneous remission of this depression [9]. In the acute 
phase, patients that had a longer inpatient hospital stay were seen to score higher 
on the Beck Depression Inventory than those that were in the community or in a 
rehabilitation facility. However, many of these studies have excluded patients that 
are aphasic, have cognitive impairment, or experienced pre-stroke depression. This 
may be one of the main reasons that poststroke depression may be underdiagnosed 
and undertreated [10].
2.1 Demographics associated with poststroke depression
Patients younger than 60 are seen to have higher depression scores poststroke. 
In the general population, major depression is more prevalent in patients younger 
than 65 years old [11]. In multiple studies that adjusted for pre-stroke depression it 
was found that more than 30% of the patients younger than 65 could be diagnosed 
as having clinical depression using the Center for Epidemiologic Studies Depression 
Scale (CES-D). It was found that within this younger age group there was a higher 
rate of depression associated with lower socioeconomic status, familial stress, and 
the ability to provide financial stability [7, 11]. However, having good social support 
has been found to be protective against poststroke depression [7, 11]. Adults over 
the age of 65 represent the majority of stroke patients, which can skew the data. 
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However, multiple meta-analyses have shown that when controlling for other vari-
ables such as sex, patients younger than 65 experienced more poststroke depression, 
and more obvious depressive phenotype [6, 11].
Biologic sex and poststroke depression is a controversial issue. Numerous 
meta-analyses have looked at the relationship between ‘gender’ and how it affects or 
predicts poststroke depression. The results were mixed when looking at data from 
across the globe. In some studies, women have been found to experience double 
the risk of poststroke depression compared to men [12, 38]. The gender disparity 
may be related to how each sex reacts to stressful life events. Women have been 
demonstrated to have more stress in reaction to negative life events, such as a stroke, 
which results in feelings of depression [12]. On self-reported survey, women were 
seen to indicate they have more depressive symptoms, compared to men, when age 
was controlled for [12]. The risk factors for women developing depression after an 
acute stroke were: pre-stroke psychiatric comorbidity, age younger than 65, and 
impairment in cognition [13]. Similarly, men with higher level of physical disability 
after a stroke had more depressive symptoms than women, or men with less physi-
cal disability. In multicenter analysis from China, and India, these studies found 
that male sex had a higher correlation with poststroke depression [10, 15]. However, 
there may be confounding factors when evaluating sex differences and poststroke 
depression. For example, in China there may be a higher number of men in the gen-
eral population [14]. In the Indian study there were more men in the study [10]. In 
the USA, it is possible that there is a higher rate of self-reporting by women, as well 
as under reporting of depressive symptoms in men, based on their level of physical 
disability [14]. Therefore, more studies need to be done in this area to determine if 
gender is a definitive predictor of poststroke depression.
Socioeconomic status and education related to poststroke depression is also 
difficult to measure, due to multiple confounders and conflicting data. However, 
reviewing the meta-analysis of patient demographics and poststroke depression has 
shown that patients with lower overall education levels have an increased risk for 
poststroke depression with mild depressive symptoms [13]. A large meta-analysis 
of the literature found that there is an association between more years of educa-
tion and lower risk for depression after a stroke. This study demonstrated that on 
average the participants in the study without poststroke depression had 0.32 years 
of education more than those that did have depressive symptoms after their stroke 
[16]. The symptoms that were seen in this data set were defined as mild depressive 
symptoms, but could not be classified as clinically depressed. However, this may 
also have confounding factors in this category. Patients that have lower socioeco-
nomic status have been shown to have lower levels of education [16]. They may also 
be exposed to environmental factors that put them at increased risk for stroke, such 
as unhealthy diet, unhealthy lifestyle, more perceived stress, exposure to second 
hand smoke, and pollution in urban areas [10, 13, 16]. These factors may increase 
their risk of stroke, and thus their risk for poststroke depression.
3. Comorbidities associated with poststroke depression
Comorbid conditions prior to a stroke can affect the development of depression 
after an acute ischemic event. Conditions such as diabetes, and preexisting psychi-
atric disorders like depression, anxiety, and bipolar disorder can all have an effect 
on poststroke depression [17, 18]. One meta-analysis has demonstrated that patients 
that have vascular risk factors such as diabetes are at a higher risk for developing 
poststroke depression [17]. This is not thought to be related to the vascular depres-
sion theory, which will be discussed later in this chapter. In a Chinese study, it was 
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shown that at 3 months after an acute stroke, patients with diabetes were more 
likely to develop poststroke depression. This was an independent risk factor for the 
development of poststroke depression at or after 3 months [17]. The hypothesis 
behind this is based on the pathophysiology behind both diabetes and poststroke 
depression, which involves the inflammatory pathway, and the hypothalamic 
pituitary access. This will be discussed later in the chapter.
Preexisting psychiatric disorders such as depression, anxiety, and bipolar 
disorder can also predispose patients to worse poststroke depression in the subacute 
phase, which is within 3 months [17]. One meta-analysis that looked at predic-
tors of poststroke depression found that of the patients that had a preexisting 
mood disorders such as dysthymia, major depression, minor depression, anxiety, 
agoraphobia and adjustment disorder were all associated with increased risk of 
worsening depression after a stroke. Of 1058 patients with reported depression 
prior to their stroke, 27% had worse depressive symptoms after the acute ischemic 
event [18]. Premorbid anxiety was also predictive of worsening anxiety after the 
stroke. Anxiety poststroke results in impaired response to adverse events increased 
perceived stress and more depressive symptoms [18].
4. Poststroke depression etiology
Poststroke depression has been defined as a mood disorder resulting from a 
general medical condition, by the Diagnostic and Statistical Manual of Mental 
Disorders (DSM) IV, meaning it does not carry with it the same definition of major 
depression [16]. There has been some debate about the etiology of poststroke 
depression, where multiple hypotheses exist, including but not limited to disrup-
tion to monoamine pathways, inflammatory cytokines, and hypothalamic–pituitary 
axis within the brain that modulates mood. The other belief is based on a psycho-
social model, where depression develops after a stroke due to inability to adjust to 
new life circumstances, inability to care for oneself, fear of recurrence, financial 
insecurity and carrying a new diagnosis [7].
4.1 Localization of poststroke depression
One question that has been analyzed extensively with no definite answers 
is the location of a stroke as a predictor of poststroke depression. These studies 
used techniques such as voxel-based symptom lesion mapping, diffusion tensor 
imaging (DTI), functional magnetic resonance imaging (MRI), and positron 
emission tomography (PET) scans [19]. Functional neuroimaging has sought to 
determine neuronal circuitry to discover how damage to these circuits results in 
mood or personality changes. These imaging modalities demonstrate that there 
is less activity in the frontal cortex, anterior cingulate, dorsolateral and caudate 
nucleus, in patients that are experiencing depression. In pilot studies using DTI, 
there has been some data demonstrating that damage to the fronto-striato thalamic 
pathway and pathways involving emotional control, reward systems and decision 
making can lead to increased risk of poststroke depression [19]. DTI changes were 
seen in stroke patients that had damage to the genu and splenium of the corpus 
callosum, frontal lobe white matter and anterior left corona radiata, resulting in 
increased levels of apathy [20]. A few theories about lesion location and depressive 
symptoms include-anhedonia as associated with the stroke volume affecting the 
hypothalamic-pituitary-adrenal axis, and increased risk for depression in patients 
with basal ganglia, and frontal lobe strokes [20]. A study by Paradiso and colleagues 
demonstrated that patients who had left hemispheric strokes were likely to have 
5Post Stroke Depression
DOI: http://dx.doi.org/10.5772/intechopen.86935
more depressive symptoms [19]. They proposed that right hemispheric strokes 
experience fewer depressive symptoms due to anosognosia. If the patient is unaware 
of his or her deficits, they will less likely feel depression related to their loss of 
function. Left hemispheric strokes have also been seen to have an earlier onset of 
poststroke depression, usually in the first 6 months poststroke [13].
One of the models that have been proposed is that subcortical strokes like those 
in the basal ganglia, and strokes in the frontal lobes can result in disrupted sero-
toninergic and norepinephrinergic pathways that can be associated with poststroke 
depression [21]. The belief is that strokes that affected the amine-containing axons 
between the brainstem and specifically the left cerebral cortex would result in 
decreased production of serotonin (5-HT) and norepinephrine [22]. A reduction of 
these neurotransmitters in the frontal and temporal lobe limbic structures, and in 
the basal ganglia could result in difficulty with mood regulation [19]. This theory 
was supported by the finding that there were low levels of the 5-HT metabolite, 
5-hydroxyindoleacetic acid in the cerebrospinal fluid (CSF).
4.2 Biomarkers associated with poststroke depression
Inflammatory cytokines were also thought to be related to the development of 
poststroke depression [23, 24]. Jioa and colleagues found that interleukin (IL)-6 
was elevated in patients with post-stroke depression, even after controlling for 
confounders, with a confidence interval of 95% [23]. The elevation of IL-6 in 
patients that have strokes could possibly predict the development of poststroke 
depression [23, 24]. In another meta-analysis, brain-derived neurotrophic factor 
(BDNF) was found to be involved in the development of depression and poststroke 
depression [25, 26]. In these studies, a low serum level of BDNF in the acute phase 
after a stroke was associated with the development of poststroke depression. BDNF 
is inherently involved in hippocampal plasticity and memory [27]. One study found 
a significant negative relationship between BDNF and NIHSS [25–27]. In rodent 
models, low levels of BDNF in the hippocampus that had an acute stroke exhibited 
depressed behavior, however if BDNF was overexpressed there was a marked 
decrease in depressed behavior [21]. Increased BDNF in the rodent model also 
resulted in reduced infarct size and improved functionality of the rodent [25].
Increased serum level of C-reactive protein (CRP), neopterin, ferritin, and glu-
tamate could also be related to poststroke depression [24]. Proinflammatory markers 
such as tumor necrosis factor (TNF)-α, interleukins (IL)-1β, IL-6, IL-1, and interferon 
gamma (IFN-γ) were associated with the development of poststroke depression [23, 
24]. Additionally, inflammatory cytokines can activate the hypothalamic pituitary 
adrenal axis [24]. Activation of the HPA access can also lead to the downstream release 
of glucocorticoids, which can also result in increased blood glucose levels, and poten-
tially diabetes if this is a chronic process. After an acute stroke, patients often exhibit 
increased levels of serum adrenocorticotropic hormone, and cortisol. These hormones 
result in higher mortality and worse neurologic outcome [23]. Increased cytokine 
activity could also result in greater expression of genes involved in the metabolism 
of tryptophan such as indoleamine 2,3 dioxygenase (IDO) [27]. If IDO expression 
increases, tryptophan will be converted to kynurenine and not 5-HT. The downstream 
effect could result in decreased levels of 5-HT in the limbic system, temporal lobes, 
frontal lobes, and basal ganglia, which could potentially result in depression [27].
4.3 Genetic association with poststroke depression
There have also been studies that have shown a genetic contribution to post-
stroke depression. Multiple studies have evaluated the 5-HT gene located on 
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chromosome 17q11.1-17q12, which encodes the serotonin transporter [25–27]. In a 
meta-analysis of 7 studies, there was a significant relationship between 5-HTTLPR 
polymorphism and the development of poststroke depression symptoms. 
5-HTTLPR is an exon of the 5-HT transporter gene polymorphism [25, 26]. The 
hypothesis is that this gene polymorphism responds to the increased activity of the 
amygdala when responding to negative stimuli. An increase in 5-HTTLPR serum 
level has been positively associated with threefold increased risk of developing 
poststroke depression [25–28]. Another 5-HT polymorphism that has been analyzed 
is the STin2 VNTR, which is located within intron 2. It has variable number tandem 
repeats 9, 10, or 12. Repeats of the 9-allele have been well documented to be associ-
ated with multiple psychiatric disorders such as bipolar disorder, and major depres-
sion [25–28]. Repeats of the twelfth allele have been linked to the development of 
schizophrenia and bipolar affective disorder. It has been demonstrated that patients 
with variable tandem repeats of 9/12 and 12/12 were likely to have more depression 
after a stroke [25–28].
4.4 Psychosocial association with poststroke depression
Lastly, psychosocial factors must be considered when assessing who is at risk for 
poststroke depression. After suffering a life-altering event such as a stroke, even 
if there are no severe deficits, patients can undergo an adjustment period. They 
may feel depressed about the new diagnosis of a stroke. There is also the concern 
of getting back to their normal life routine such as working, caring for dependents, 
and caring for their own activities of daily living (ADLS) [11, 12]. Patients that do 
not have good social support tend to experience more depression after a stroke due 
to feeling helpless, and alone. Patients may also experience anxiety, related to the 
fear that another stroke may occur. Financial costs of health care also play a role in 
postacute stroke depression. If a patient is unable to work there may be a concern 
about medication compliance, affording medication, affording postacute special 
services like physical therapy or occupational therapy [11, 12].
5. Poststroke depression in elderly
Although there is a growing prevalence of stroke in patients aged 65 and 
younger, the majority of strokes affect patients that are elderly. With the prolonged 
life expectancy, there is an increased risk for stroke in the aging population, with 
70% risk being after the age of 65 [29]. In patients older than 80 years old that 
suffer from strokes, there is a greater risk of fatality, prolonged hospitalization, 
complications, and increased postacute care needs [30]. In elderly patients that 
suffer from stroke, depression may be difficult to diagnose. This is largely due to the 
symptoms being a vegetative phenotype. It is also confounded because depression 
is the most common psychiatric disorder among the elderly—with 1% of the elderly 
population having a formal diagnosis of major depression, and 15% with depressive 
symptoms according to the National Institutes of Health Consensus development 
conference [31]. This poses a challenge that practitioners face in distinguishing 
between premorbid depression, inherent stroke symptoms and poststroke depres-
sion, given that many of the features overlap. Some such features include cognitive 
impairment, psychomotor retardation, and social withdrawal [29]. One measure 
used to assess poststroke depression in the elderly is the geriatric depression scale 
(GDS) [32]. This is a self-reported scale where patients answer yes and no questions 
to determine if a patient is experiencing some form of depression. A score greater 
than 6 indicates that the patient is likely experiencing some form of depression. 
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This scale is highly sensitive and predictive of poststroke depression in the geriatric 
population [32]. However, the GDS cannot be used by aphasic stroke patients or 
those with cognitive impairments caused by a stroke.
5.1 Vascular dementia and poststroke depression
Alexopoulos and colleagues found that elderly stroke patients that suffered 
ischemic strokes demonstrated increased encephalomalacia and MRI hyperintensi-
ties that would predispose these patients to develop depression [33]. Their study 
suggested that these changes were not seen in elderly patients that had depression 
without vascular risk factors. Elderly patients that have been observed to have 
signs of depression, but do not have any vascular risk factors were found to have 
less white matter hyperintensities on MRI, which were similar to the nondepressed 
controls [31]. It has also been demonstrated that patients that suffered from depres-
sion without vascular insult had phenotypically different depression with features 
of more agitation, aggression, feelings of guilt and dysphoria. This is the theory of 
vascular depression in the elderly [33]. The hypothesis behind vascular depression 
states that chronic small vessel changes or non-symptomatic cerebrovascular events 
accumulate over time, resulting in the disruption of cortico-striato-pallido-thal-
amo-cortical (CSPTC) pathways [31]. Vascular dementia is described as a subcorti-
cal phenomenon. This type of depression differs from poststroke depression, in that 
they are silent, and the patient is not aware that they have suffered a stroke [31]. In 
a Japanese sample, greater than 80% of the patients that had major depression had 
MRI evidence of multiple silent infarcts [32]. Up to 75% of these depressed patients 
had lesions in the basal ganglia and thalamus [31, 33].
Three pathways associated with CSPTC were proposed in the way that vascular 
depression can present phenotypically. Within the CSPTC are the orbitofrontal 
pathway, the cingulate pathway, and the dorsolateral pathway. Injury over time to 
the orbitofrontal pathway can result in irritability and disinhibition [31]. The cin-
gulate pathway can cause apathy, and lack of initiative if injured, and lastly, injury 
to the dorsolateral pathway can result in poor speech productions, and inability to 
learn. These symptoms can all be seen in elderly depression. Prefrontal dysfunction 
has shown to have a poor or delayed response to antidepressants in elderly patients 
[31, 33]. However, early administration of antidepressants, particularly selective 
serotonin reuptake inhibitors have been shown to improve neuropsychological 
rehabilitation in elderly stroke patients.
Lacunar infarcts have been seen to result in more depression among Alzheimer 
patients especially basal ganglia strokes and cortical strokes were found to have 
more cognitive impairment [31]. Severe cognitive impairment was also seen to be 
one of the leading causes of depression in the elderly. There are some questions of 
whether cognitive impairment or dementia can increase the risk of stroke, and thus 
poststroke depression among the elderly, or do strokes result in cognitive decline 
and vascular depression [31]. Dementia and depression can be difficult to dif-
ferentiate. In the elderly, pseudodementia can be secondary to depression however, 
the opposite is also true. This is a “what came first” type of scenario with dementia, 
stroke and vascular depression [31].
Although vascular depression and poststroke depression are different in the way 
they affect a patient, they likely lay on a continuum. Both are secondary to a vascu-
lar event, and both result in depression. Vascular depression has a higher incidence 
in elderly patients as they have an accumulation of more subcortical white matter 
changes that are seen as hyperintensities on MRI FLAIR. Poststroke depression is 
less subtle since the patient is usually aware that they have had a stroke [31, 33]. 
There may be a growing incidence of vascular depression among young patients, 
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due to poorly controlled hypertension, tobacco, diabetes, drug use, and poor diet 
and lifestyle choices causing small vessel disease. These risk factors put all patients 
at risk for an acute stroke, and chronic small vessel disease.
6. Large strokes and the effect on poststroke depression
In patients that suffer from large ischemic or hemorrhagic strokes, they are 
often left with a serious physical disability [2]. A proximal middle cerebral artery 
occlusion can result in severe expressive, or receptive aphasias, hemiparesis, facial 
weakness, sensory loss inability to swallow, neglect, apraxia, and a propensity 
toward developing seizures [34]. If the patient is relatively young, the probability of 
cerebral edema is high, which could result in complications such as brain herniation 
if a hemicraniectomy is not performed. Intracerebral hemorrhage in these vascular 
territories can result in similar findings that may necessitate an extra ventricular 
drain to remove blood from the ventricles, or a decompressive hemicraniectomy 
to evacuate the hemorrhage [34]. A patient with a large stroke in the posterior 
circulation can result in the patient being obtunded, having chronic balance issues, 
hemiparesis, vision loss, and ataxia [3].
Patients that survive these large strokes often experience the most debility, 
with the majority becoming bedbound, requiring a percutaneous endoscopic 
gastrostomy tube for nutrition and tracheostomy tube for assistance with breathing. 
Due to the severity of their disability, these patients require 24-hour care, by their 
families or nursing professionals. The majority of these patients experience severe 
depression and guilt, due to feeling like a financial or physical burden on their loved 
ones [35]. They also experience loss of autonomy due to their deficits. They are no 
longer able to manage their own activities of daily living, which results in feelings of 
inadequacy, and resentment for those that are doing the caregiving. Depression has 
also seen to be positively correlated with the national institute of health stroke scale 
(NIHSS) which measures stroke severity, wherein the higher the stroke scale, the 
more severe the depressive symptoms [36].
Patients with large strokes and increased debility often require management in 
a skilled nursing facility (SNF). At SNF, the patients do not participate in as much 
rehabilitation activities, as compared to other stroke patients in an inpatient reha-
bilitation setting [32]. These patients are therefore at disadvantage because their 
exposure to rehabilitation is limited. The combination of decreased functionality, less 
access to rehabilitation, and depression impairs the recovery for these patients. They 
too lose the desire to participate in meaningful interaction due to their disability [32].
7. Challenges in diagnosing depression after stroke
Diagnosing depression after a stroke may be difficult for practitioners given 
that stroke patients can have complex symptoms. The physicians that treat stroke 
patients should be aware that over a third of patients experience depression after a 
stroke, and to note that even subtle changes in behavior could represent an aspect 
of poststroke depression [17]. Small changes like irritability, frustration, extreme 
fatiguability, and refusing to partake in physical therapy and occupational therapy. 
Another challenge is that many symptoms of stroke and depression overlap, such 
as fatigue, pain, decreased motor activity, and decreased verbal output [7]. Only 
a few of the depression scales used to assess poststroke depression include somatic 
symptoms in their evaluation. The Beck Depression Inventory is one such scale. 
However, again some somatic symptoms from the stroke itself can be mistaken as a 
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positive finding on a depression scale. It is important to be able to tease apart what 
symptoms are due to a stroke and what symptoms are related to depression. If a 
diagnosis of poststroke depression is missed, it can negatively affect how the patient 
recovers, and even affect their mortality.
The symptoms that make the diagnosis of poststroke depression the most dif-
ficult are aphasia, anosognosia, neglect, abulia and cognitive disabilities that result 
from their stroke [37]. Unfortunately, the majority of studies that evaluate poststroke 
depression exclude patients with these symptoms. This is largely due to their inability 
to answer questions, fill out questionnaires, or because it is difficult for medical staff 
to assign a score to the patient based on their daily interactions. Aphasia is indepen-
dently associated with an increased risk of developing poststroke depression [37]. 
However, three scales have been developed to assess depression in aphasic patients. 
These scales include the Stroke Aphasic Depression Questionnaire-10 (SADQ-10), 
the Aphasia Depression Rating Scale (ADRS), and the Perceived Stress Scale (PSS). 
The (SADQ/SADQ-10/SADQH-10) and the Aphasia Depression Rating Scale are 
based on the observation of other people to determine if the patient being assessed 
is in fact depressed or not. The SADQ-10 used caregivers as the observers, with 
non-aphasic patients as the controls [37]. A value of 14/30 or higher was correlated 
with the development of depression and depressive symptoms with a sensitivity of 
70% and specificity of 77%. The ADRS scoring system used external signs that could 
be observed such as fatigue, insomnia, changes in weight, and signs of anxiety. A 
score of 9/30 or higher was associated with the development of depression with a 
sensitivity of 83% and specificity of 71% [37]. After a comparative analysis, it was 
determined that either one of these tools could be used for assessing depression 
in aphasic patients. A review of the current studies could be more generalizable if 
aphasic patients were included and analyzed with these scales.
8. Poststroke depression effect on morbidity and mortality
Poststroke depression was found to be an independent predictor of symptom 
severity after a stroke, and difficulty with managing activities of daily living [35]. In 
a meta-analysis of seven studies, poststroke depression was found to have an asso-
ciation with increased mortality [39]. Specifically, patients that experienced early 
poststroke depression as defined to be within 3 months of stroke onset, were found 
to have 1.5 increased risk of death. A literature review by Robinson and colleagues, 
found that using the Hospital Anxiety and Depression scale (HADS), patients that 
had a score greater than 7 at 3 months had increased mortality than those with a 
score less than 7 [38]. These scores were evaluated up to 5 years poststroke, and the 
hazard ratio was found to be 1.41. It was seen that mortality was increased in patients 
with poststroke depression that were younger than 65 years old [38]. Their study also 
demonstrated that in greater than 50,000 veterans that suffered an ischemic stroke, 
those that developed poststroke depression had higher rates of mortality within 
3 years of that acute event. The hypothesis behind this being that early poststroke 
depression can occur in a patient with a severe disability such as neurocognitive 
decline, paralysis, aphasia, or dysphagia [38]. Due to the severity of their post-stroke 
symptoms these patients may be at increased risk of death due to complications like 
pneumonia secondary to dysphasia or infection from decubitus ulcers. Another 
hypothesis is that patients that are suffering from poststroke depression may be 
less likely to be compliant with medical recommendations, such as healthy diet, 
avoiding tobacco, alcohol, drug use, scheduled follow up appointments and medica-
tion compliance [37, 38]. These factors can increase the risk of mortality. Another 
theory states that mortality associated with poststroke depression may be related to 
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cardiovascular mortality [38, 39]. There is an association between depression and 
myocardial infarction, where it was found that depressed patients had less heart rate 
variability. This finding was also seen in patients with poststroke depression. This 
could put these patients at risk for myocardial infarction and subsequently, death. 
This meta-analysis also highlighted the idea that pharmacologic antidepressants have 
a mixed response in poststroke depression [38].
9. Treatment of poststroke depression
In order to treat poststroke depression, it needs to be accurately diagnosed. 
Currently the DSM IV is used to diagnose this disorder, along with multiple depres-
sion rating scales such as the Hamilton Rating Scale for Depression, Beck Depression 
Inventory, Montgomery-Åsberg Depression Rating Scale, Center for Epidemiological 
Studies Depression Scale, Zung self-rating depression scale and the Post-Stroke 
Depression Rating Scale [5]. There are many challenges in diagnosing depression in a 
patient after an acute stroke. Many of these patients have a somatic component to their 
symptoms, like pain, fatigue, or limited speech after a cerebrovascular event. These 
symptoms can confound a depression scale that account for somatic symptoms—
like the Beck Depression Index [5]. Depending on which scale is used to measure 
depression in these patients, there may be an overestimation or underestimation of 
depression. Since the hypothesis that stroke results in disruption of the monoamine 
pathways, there has been a focus on antidepressants like selective serotonin reuptake 
inhibitors, or tricyclic antidepressants to target poststroke depression. However, the 
role of antidepressants has been debated. There are some studies that show efficacy 
and reduction in mortality, and some that show a minimal effect or even adverse side 
effects [38–40]. Selective serotonin reuptake inhibitors (SSRIs) are well tolerated and 
can lead to fewer symptoms of depression at 3 weeks of use [40]. It is one therapy that 
is thought to work well in all age groups, regardless of comorbid conditions. SSRIs are 
better tolerated in all populations, compared to tricyclic antidepressants (TCA) [39, 40]. 
One endpoint found that patients that were started on SSRI early had decreased risk 
of myocardial infarction and recurrent stroke [40]. In a meta-analysis by Robinson 
and colleagues, the use of nortriptyline or fluoxetine demonstrated improvement in 
activities of daily living in poststroke depression compared to patients on placebo [38]. 
This study also demonstrated that the continued use over 12 weeks resulted in 
improved cognition in patients with poststroke depression, where the effect could last 
up to 2 years. Not only do SSRI inhibit reuptake of serotonin, but it was demonstrated 
in rodent models that SSRIs can decrease infarct volumes, reduced inflammation and 
increase neuroplasticity by modulating BDNF expression [38]. SSRI was also found to 
increase neurogenesis in the hippocampus, and improve cerebral blood flow autoregu-
lation which is thought to be related to the upregulation of BDNF [27, 38].
In the fluoxetine in motor recovery of patients with acute ischemic stroke 
(FLAME) trial, fluoxetine use for 3 months was tested to see if it would improve 
motor recovery in patients with hemiparesis [41]. This trial was used to assess if the 
use of fluoxetine would change the Fugl-Meyer motor scale (FMMS) score which 
is an index used to test motor recovery, with a score of 100 representing complete 
motor function without any deficit. Two groups were analyzed a fluoxetine dose of 
20 mg was the placebo and a 40 mg dose was used as the test treatment. At 3 months 
there was a significant improvement in motor function among the patients in the 
treatment arm [41]. At 90 days modified rankin scale (MRS) scores were better in 
the treatment arm as well. The frequency of depression was lower in the treatment 
arm when assessed with the MADRS score at 90 days. Even in patients that did not 




treatment arm. Patients that were assessed to be depressed at the onset of the trial, 
based on MADRS score, were excluded from this trial [41]. Pretreatment with SSRI 
prior to stroke was also an exclusion criterion. Although the FLAME trial seemed 
to be promising for improving motor function in poststroke patients and reducing 
depression within that 3-month period, newer studies have shown the use of SSRI 
prior to stroke, was negatively associated with ambulation poststroke [8].
In a study by Etherton et al., it was found that the use of SSRI prior to an acute 
stroke was associated with a decrease in discharges back to the patient’s home, and 
increasing need for ambulatory aids [8]. When examining the patients in the two 
groups: pre-SSRI/spread vs. non antidepressant, there were no significant differ-
ence in admission NIHSS or length of hospital stay. The authors thought this may 
be due to the possibility that patients that were on SSRI or antidepressants prior to 
admission for their stroke event may have suffered a stroke before or TIA, result-
ing in a larger stroke burden. Another ischemic event could cause recrudescence 
of old stroke symptoms due to an increased burden on that area that was receiving 
adequate blood flow, which could lead to the patient having more needs such as 
rehabilitation at discharge. Pre-SSRI use was also associated with increased mortal-
ity at 30 days, and worse stroke severity in patients with hemorrhagic stroke [8].
Another criticism for the use of SSRIs was due to the increase in the risk of major 
bleeding or death. In a meta-analysis of 31 case-controlled studies, it was found that 
SSRI use was associated with risk of major bleeding events, with the increased risk 
being 41% [40, 42]. This meta-analysis also examined cohort studies that evaluated the 
use of SSRI vs. non-SSRI in association with major bleeding risk of 36%. The pooled 
data from the meta-analysis found that SSRI was associated with major bleeding risk 
with an odds ratio of 1.41. Gastrointestinal bleeding accounted for the majority of these 
major bleeding events, with a few intracerebral hemorrhage cases [42]. The hypothesis 
behind the increased bleeding risk is that platelet activity is inhibited by serotonin. This 
hypothesis is strengthened by the idea that patients taking SSRI have less myocardial 
infarctions and fewer strokes. The major bleeding risk associated with SSRI are ampli-
fied with adjunct use of non-steroidal anti-inflammatory drugs (NSAIDS) [42].
Overall, antidepressants such as SSRI and TCA have been thought to be the best 
initial treatment for post-stroke depression. SSRI are overall better tolerated in all 
populations [40]. These antidepressants can help patients combat poststroke depres-
sion enough to allow them to participate in rehabilitation efforts. Psychotherapies 
such as cognitive behavioral therapy (CBT) have been studied to assess if it would be 
beneficial in the treatment of poststroke depression. Due to the small sample size of 
the studies, and other limitations there was no real effect seen with CBT [5]. It may 
be an area of adjunct therapy for patients with severe poststroke depression that need 
more than pharmaceutical treatment. However, the use of CBT should not delay the 
initiation of treatment with antidepressants.
10. Depression and stroke rehabilitation
Depression after stroke strongly affects the way patients participate in and respond 
to rehabilitation. Depression has been linked with decreased participation in reha-
bilitation efforts which in turn results in more increased morbidity and mortality and 
decreased quality of life. In a Japanese study that evaluated poststroke depression 
in patients admitted to a rehabilitation center, their results demonstrated that the 
patients that were identified as having poststroke depression had less response to rehab 
and minimal improvement in activities of daily living and functional independence 
measures [32]. This study found that the level of independence in the activities of daily 
living at the time of discharge from rehab was related to the severity of poststroke 
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depression at the time of admission. Poststroke depression had a negative 5-year 
correlation with the ADL. Psychological factors accounted for a large part of how 
patients responded to rehabilitation [32]. This study found that patients with post-
stroke depression experience feelings of hopelessness and were thus not motivated to 
participate in rehabilitation. Depression in these patients also leads to listlessness and 
inattention, which predisposed the patients with poststroke depression to falls. Thus, 
another reason why mortality is higher in patients with poststroke depression. Falling 
was also correlated with a decreased ability to manage their ADL [32].
Another study on depression and rehabilitation found that patients with hemiparesis 
and poststroke depression had 51% less participation in rehabilitation activities [43]. This 
study showed that any amount of depression after a stroke can affect a patient’s quality of 
life despite the severity of the stroke. This is because each patient has a unique response 
to acute stress. The perceived stress score is valuable in rehabilitation because it helps 
practitioners identify which patients are more at risk of developing depression. If they are 
identified early, treatment of depression can be initiated, and rehabilitation does not need 
to be adversely affected. Some of the indexes used to measure the quality of life in patients 
with poststroke depression include the Stroke Specific Quality of Life Scale SS-QOL, 
stroke impact scale, Barthel index of ADL as well as the multiple depression rating scales 
[43]. The Scandinavian Stroke Scale (SSS) and Bergman Balance Scale (BBS) are mea-
sures used to assess the progress of rehabilitation, which is more encompassing than the 
Modified Rankin Score [10]. If patients are able to meaningfully participate in rehabilita-
tion, studies have proven that symptoms of depression can improve, and their quality 
of life scores increase as well [43]. This coupled with the use of antidepressants can help 
patients with depression poststroke manage their symptoms of depression and improve 
their functional outcome. It could also help prevent a subsequent ischemic event [43].
Depression has also been found to be a risk factor for stroke [44]. This has been 
demonstrated even when controlling for confounders like tobacco use or substance 
use. Patients with psychosocial stressors put patients at an increased risk of stroke [11, 
12, 44, 45]. Not only do these patients have an increased risk of hypertension, and 
diabetes, but also have an increased prevalence of tobacco use and substance use that 
also put them at greater risk for an ischemic stroke [44]. A meta-analysis by Dong and 
colleagues, looked at 17 prospective studies that included greater than 200,000 patients 
[45]. Of this subset of patients, greater than 6000 had a positive association between 
depression and a second stroke. A depressed patient had 34% higher risk of developing 
stroke, even when age and sex were controlled for [45]. Thus, stroke and depression 
may be a part of a vicious cycle where a stroke results in depression and then depres-
sion results in another stroke. This process repeats and, in turn, hinders recovery and 
rehabilitation. Thus, proving again why it is important to diagnose depression after a 
stroke, and treat it adequately.
11. Poststroke depression and effect on the health care system
Poststroke depression can increase the burden on the healthcare system. In two 
literature reviews the effect of depression after a stroke was assessed by looking at 
large veteran populations [46, 47]. These studies demonstrated that patients that 
suffered from poststroke depression had on average a longer hospital stay, as well 
as increased outpatient and inpatient physician visits over 1 year. These patients 
also had a higher likelihood of having significant deficits such as dysphagia after 
their stroke, and complex comorbidities that required frequent hospital visits, or 
prolonged stays in nursing facilities/rehabilitation centers [47]. They were also 
noted to have higher risk of a subsequent stroke within 1 year of their first stroke, 




pneumonia, or falls [47]. In Husaini and colleague’s analysis of 17,010 patients 
from Tennessee, their study demonstrated that patients with stroke and depression 
had higher average health care costs than patients with only stroke, or stroke with 
another comorbid psychiatric disorder, even while controlling for age, sex and race 
[48]. On average stroke patients with depression had a healthcare cost of $77,864, 
compared to $47,790 in patients with stroke only these costs are due to increase use 
of diagnostic tests, increased pharmacologic interventions, and addition therapist 
and physician consultations [47, 48]. If poststroke depression could be identified 
early, and treated it could reduce the total cost to the patient, and could decrease the 
overall healthcare burden (Figure 1).
Figure 1. 
The diagnostic and treatment procedures of PSD. MDD = major depressive disorder; PSD = poststroke 
depression [49].
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12. Conclusion
Depression and stroke have a bidirectional relationship where one acts as a risk 
for the other. Poststroke depression is an area of study that has evolved over the 
years. New studies on its etiology have been discovered, and continued research 
efforts are providing more insight on the questions we still have, such as the associa-
tions of lesion location, the role of inflammation, neuroplasticity, and even genet-
ics. Some patients are more at risk than others for developing poststroke depression, 
but the main goal is detection, management, and rehabilitation. Detecting post-
stroke depression is important, so treatment can be initiated as soon as possible, 
thus reducing morbidity, mortality, and assisting these patients with participating 
in rehabilitation efforts. Rehabilitation not only improves function in these patients, 
but also has beneficial effects on depression as well. If patients can effectively 
partake in rehabilitation efforts, their quality of life scores have been shown to 
improve (with quality of life being a measure for depression in these patients). 
Improvements in perceived quality of life can have downstream effects resulting in 
a reduction of readmissions to the hospital, and outpatient visits, and thus a reduc-
tion in the healthcare burden caused by this disease process. If depression can be 
effectively managed, patients will be more likely to have meaningful participation 
in poststroke rehabilitation, and reduce the risk of morbidity and mortality associ-
ated with their stroke.
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